psa progression
Showing 1 - 11 of 11
PSA Progression, Stage III Prostate Adenocarcinoma, Stage IV Prostate Adenocarcinoma Trial in Canada, United States (drug,
Active, not recruiting
- PSA Progression
- +2 more
- Apalutamide
- +2 more
-
Gilbert, Arizona
- +362 more
Mar 9, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Houston, Texas
- +2 more
Feb 11, 2022
Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two Trial in Palo Alto (procedure,
No longer available
- Prostate Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jan 6, 2022
PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7
Active, not recruiting
- PSA Level Greater Than 0.03
- +4 more
- Antiandrogen Therapy
- +2 more
-
Los Angeles, California
- +1 more
Oct 14, 2021
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Los Angeles
Completed
- Biochemically Recurrent Prostate Carcinoma
- +8 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 29, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, PSA Progression Trial in San Francisco (Apalutamide,
Recruiting
- Castration Levels of Testosterone
- +3 more
- Apalutamide
- Stereotactic Body Radiation Therapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 26, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue
Withdrawn
- Castration Levels of Testosterone
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 31, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in
Recruiting
- Castration Levels of Testosterone
- +4 more
- HER2Bi-Armed Activated T Cells
- +2 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Feb 26, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
-
Detroit, Michigan
- +1 more
Nov 11, 2020
Drug Resistance in Metastatic Castration-Resistant Prostate
Completed
- Castration Levels of Testosterone
- +5 more
- Cytology Specimen Collection Procedure
- +2 more
-
Los Angeles, California
- +2 more
Sep 24, 2020
Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma in the Soft Tissue Trial in
Terminated
- Castration Levels of Testosterone
- +5 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 29, 2018